Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Czech Republic
Summary - Ramucirumab, Gilteritinib, Glofitamab 2025
Deadline - Apr 14, 2025
GT reference number - 104816044
Product classification - Antineoplastic and immunomodulating agents
Address - Czech Republic
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 104816044
Document Type - Tender Notices
Description - Description: The subject of the public contract is recurring supplies of medicinal products meeting SUKL requirementslocal title:: RAMUCIRUMAB, GILTERITINIB, GLOFITAMAB 2025Contract Duration: : 36 MONTHContract Type: : Supplylocal description: : Pře dmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků splňujících požadavky SÚKL lot_details: 1: Ramucirumab, 2: Gillter, 3: GLOFITAMAB
Gt Ref Id - 104816044
Deadline - Apr 14, 2025
Similar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
